Loading Mouse GIF
Loading...

Strain Name:
STOCK Acetm6Keb/Mmucd
Stock Number:
076122-UCD
Citation ID:
RRID:MMRRC_076122-UCD
Other Names:
ACE10/10

Strain Information

QUALITY CONTROL OF STOCK Acetm6Keb/Mmucd  |  University of California at Davis
Last Updated:
Strain Data and Information Information by Submitter Assessed by MMRRC1,2
Published Provided
Allele-specific genotype3n.d.
Genetic backgroundn.d.
Viability of genotypes available for distributionn.d.
Specific Pathogen- Status n.d.
Recoverability of cryopreserved sperm/embryos4 n.d.
Gene or allele sequence3 n.d.
Gene or allele expression3n.d.
Gene or allele function3n.d.
Observable and/or measurable phenotypesn.d.
Fertility of genotypes available for distribution n.d.
Fecundity/breeding performance n.d.

1 When indicated as "assessed by MMRRC" ("YES"), please note that the information presented on this strain is to the best of our knowledge correct and up-to-date at the the MMRRC Distribution Center assigned to maintain and distribute this strain. This information is subject to change due to breeding, maintenance, and other actions. Please direct any questions on the information presented in this table to the MMRRC Distribution Center.

2 If an assessment has not been performed by the MMRRC (as indicated by "NO"), investigators may request specific testing for a fee. Requests should be submitted directly to the MMRRC Distribution Center assigned to the management, archiving, and distribution of the strain. A full listing of available testing and analytical services is available at https://www.mmrrc.org/about/services.php.

3 This information may or may not apply to each individual engineered allele (e.g., Cre, FlpO) present in the strain.

4 Recovery refers to thawing, in vitro fertilization (IVF), and/or embryo culture leading to live offspring.

Acetm6Keb
Name: angiotensin I converting enzyme; targeted mutation 6, Kenneth E Bernstein
Type: Allele
Species: Mus musculus (mouse)
Chromosome: 11
Alteration at locus: Targeted Mutation
Ace
Name: angiotensin I converting enzyme
Type: Gene
Species: Mus musculus (mouse)
Chromosome: 11
NCBI: 11421
HGNC: HGNC:2707
Homologene: 37351
Genetic Alterations

A 7.2 kb fragment of DNA encoding the mouse colony stimulating factor 1 receptor promoter, first and second exons and the first and second introns was inserted into the locus. The promoter had been modified so that the translation start site normally present in exon 2 was nonfunctional.

ES Cell Line
R1
Phenotype

As seen in Figure 3, of PMID:38763333, mice named ACE10/10 are homozygous (HOM) for the mutation.

Heterozygous and HOM mice for this mutation are both viable/fertile.

  • ACE expression is driven by c-fms promoter, resulting in ACE expression exclusively in monocytes and macrophages.
  • HOM mice have higher levels of ACE expression in monocytes and macrophages, demonstrate resistance to tumor proliferation, specifically melanoma and lymphoma.
    • 16 to 25-fold increase compared to normal levels
    • Macrophages highly effective at metabolizing lipids
    • Some increase in other myelomonocytic cells but less drastically than in monocytes or marophages
    • Lack ACE expression in endothelial cells, renal epithelial cells, and other tissues
    • Increased immune function
MeSH Terms
  • Angiotensinogen/genetics
  • Angiotensinogen/metabolism
  • Animals
  • Bone Marrow Transplantation
  • Cell Line, Tumor
  • Gene Targeting
  • Humans
  • Interleukin-10/blood
  • Interleukin-12 Subunit p40/blood
  • Macrophages/enzymology
  • Melanoma, Experimental/metabolism
  • Melanoma, Experimental/pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Nitrites/metabolism
  • Promoter Regions, Genetic
  • Renin/genetics
  • Renin/metabolism
  • Skin Neoplasms/metabolism
  • Skin Neoplasms/pathology
  • Tissue Distribution
  • Peptidyl-Dipeptidase A/metabolism
  • Peptidyl-Dipeptidase A/genetics
  • Myeloid Cells/metabolism
  • Myeloid Cells/immunology
  • Myeloid Cells/drug effects
  • Macrophages/metabolism
  • Macrophages/immunology
  • Macrophages/drug effects
  • Neutrophils/immunology
  • Neutrophils/metabolism
  • Neutrophils/drug effects
  • Renin-Angiotensin System/drug effects
  • Angiotensin II/pharmacology
  • PPAR alpha/metabolism
  • PPAR alpha/genetics
  • Melanoma, Experimental/immunology
  • CD8-Positive T-Lymphocytes/immunology
  • Proteomics/methods
  • Angiotensin-Converting Enzyme Inhibitors/pharmacology
  • THP-1 Cells
  • Lisinopril/pharmacology
  • Proteome/metabolism
  • Tryptophan/metabolism
  • Alzheimer Disease/genetics
  • Alzheimer Disease/pathology
  • Alzheimer Disease/prevention & control
  • Alzheimer Disease/enzymology
  • Microglia/enzymology
  • Microglia/metabolism
  • Disease Models, Animal
  • Amyloid beta-Peptides/metabolism
  • Phagocytosis
  • Plaque, Amyloid/pathology
  • Receptors, Immunologic/metabolism
  • Membrane Glycoproteins/metabolism
  • Proprotein Convertase 9/metabolism
  • Lipid Metabolism
  • Cholesterol/metabolism
  • Atherosclerosis/genetics
  • Atherosclerosis/prevention & control
  • Angiotensins/metabolism
  • Adenosine Triphosphate/metabolism
  • ATP Binding Cassette Transporter 1/genetics
  • ATP Binding Cassette Transporter 1/metabolism
Strain GQC Summary
Gene Specific Genotyping:

To request gene-specific and other genotyping services for a strain, please contact the distribution MMRRC Center for more information.

Background Genetic Quality:

The MMRRC has developed a Genetic Quality Control pipeline using the MiniMUGA array to provide additional information to identify and validate genetic backgrounds of MMRRC strains. For more information on whether genetic background data is available, please contact MMRRC_GeneticQC@med.unc.edu. Note: that MiniMUGA genetic background data is not available on all strains, but can be ordered if desired.

Suggested Control Mice
Littermates of all relevant genotypes.
  • Cancer
  • Cardiovascular
  • Immunology and Inflammation
  • Neurobiology
Submitter
Kenneth Bernstein, M.D., Cedars-Sinai Medical Center.
Primary Reference

Shen XZ, Li P, Weiss D, Fuchs S, Xiao HD, Adams JA, Williams IR, Capecchi MR, Taylor WR, Bernstein KE. Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Am J Pathol. 2007 Jun;170(6):2122-34. doi: 10.2353/ajpath.2007.061205. (Medline PMID: 17525278)

Bernstein KE, Cao D, Shibata T, Saito S, Bernstein EA, Nishi E, Yamashita M, Tourtellotte WG, Zhao TV, Khan Z. Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function. J Biol Chem. 2024 Jun;300(6):107388. doi: 10.1016/j.jbc.2024.107388. Epub 2024 May 17. (Medline PMID: 38763333)

Saito S, Cao DY, Bernstein EA, Shibata T, Jones AE, Rios A, Hoshi AO, Stotland AB, Nishi EE, Van Eyk JE, Divakaruni A, Khan Z, Bernstein KE. Peroxisome proliferator-activated receptor alpha is an essential factor in enhanced macrophage immune function induced by angiotensin-converting enzyme. Cell Mol Immunol. 2025 Mar;22(3):243-259. doi: 10.1038/s41423-025-01257-y. Epub 2025 Feb 5. (Medline PMID: 39910334)

Oosthuizen D, Ganief TA, Bernstein KE, Sturrock ED. Proteomic Analysis of Human Macrophages Overexpressing Angiotensin-Converting Enzyme. Int J Mol Sci. 2024 Jun 27;25(13):7055. doi: 10.3390/ijms25137055. (Medline PMID: 39000163)

Gomez AR, Byun HR, Wu S, Muhammad AKMG, Ikbariyeh J, Chen J, Muro A, Li L, Bernstein KE, Ainsworth R, Tourtellotte WG. Boosting angiotensin-converting enzyme (ACE) in microglia protects against Alzheimer's disease in 5xFAD mice. Nat Aging. 2025 Jul;5(7):1280-1294. doi: 10.1038/s43587-025-00879-1. Epub 2025 Jun 9. (Medline PMID: 40490625)

Cao D, Khan Z, Li X, Saito S, Bernstein EA, Victor AR, Ahmed F, Hoshi AO, Veiras LC, Shibata T, Che M, Cai L, Temel RE, Giani JF, Luthringer DJ, Divakaruni AS, Okwan-Duodu D, Bernstein KE. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism. Cardiovasc Res. 2023 Aug 7;119(9):1825-1841. doi: 10.1093/cvr/cvad082. Erratum in: Cardiovasc Res. 2024 Jul 2;120(8):971. doi: 10.1093/cvr/cvae013. (Medline PMID: 37225143)

Strain Development

Generated in 129 ES cells, backcrossed to C57BL/6 for at least 10 generations.


Disclaimer: If MMRRC Strain Genetic Quality Control (GQC; based on MiniMUGA genotyping and analysis) has been completed for this strain, the information might differ from the genetic background information provided by the submitter. MiniMUGA genetic analysis is done on a strain's tissue samples taken when archived by or ordered from the assigned MMRRC Center.

Colony and Husbandry Information

Colony Surveillance Program and Current Health Reports

Mice recovered from a cryo-archive will have health surveillance performed on recipient females. Health reports will be provided prior to shipment. If you require additional health status information, please email mmrrc@ucdavis.edu.
Coat Color
Black
Eye
Black
MMRRC Breeding System
Sib-mating
Generation
Crossed back to BL6 more than 10 times
Overall Breeding Performance
Excellent
Viability and Fertility: Female Male Comments
Homozygotes are viable: Yes Yes
Homozygotes are fertile: Yes Yes
Heterozygotes are fertile: Yes Yes
Age Reproductive Decline: Greater than 12 months Greater than 12 months
Average litter size
4 to 6
Recommended wean age
3 Weeks
Average Pups Weaned
4 to 6

Order Information

Limited quantities of breeder mice (recovered litter) are available from a cryoarchive; recovered litter usually available to ship in 3 to 4 months.

A Commercial License Agreement from the Submitter is required for for-profit entities to use this strain. For more information, please contactChristopher Sue.

Distribution of this strain requires submission of the MMRRC Conditions of Use (COU). A link to the COU web form will be provided via email after an order has been placed; the form should be completed then or the email forwarded to your institutional official for completion.

A Commercial License Agreement from the Submitter is required for for-profit entities to use this strain. For more information, please contact Christopher Sue

Additional charges may apply for any special requests. Shipping costs are in addition to the basic distribution/resuscitation fees. Information on shipping costs and any additional charges will be provided by the supplying MMRRC facility.

Click button to Request this one strain. (Use the MMRRC Catalog Search to request more than one strain.)
MMRRC Item # Description Distribution Fee / Unit (US $)
*Shipping & Handling not included*
Units Notes
076122-UCD-RESUS Litter recovered from cryo-archive $5,892.91 / $6,181.91
Non-Profit / For-Profit
Litter Recovered litter4; additional fees for any special requests.

1 The distribution fee covers the expense of rederiving mice from a live mouse; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.

2 An aliquot contains a sufficient number of embryos (in one or more vials or straws and based on the transfer success rate of the MMRRC facility) to transfer into one to three recipients. The MMRRC makes no guarantee concerning embryo transfer success experienced in the recipient investigator's laboratory. Neither gender nor genotype ratios are guaranteed.

3 An aliquot is one straw or vial with sufficient sperm to recover at least one litter of mice, as per provided protocols, when performed at the MMRRC facility. The MMRRC makes no guarantee concerning the success of these procedures when performed outside the MMRRC facilities.

4 The distribution fee covers the expense of resuscitating mice from the cryo-archive; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.

To request material from the MMRRC: Please fill out our on-line request form (accessible from the catalog search results page, or click the Request this Strain button in the fees section). If you have questions or need assistance completing this form, you may call Customer Service at (800) 910-2291 (in USA or Canada) or (530) 757-5710 (international calls). Before you call, please have with you: the MMRRC item number, quantity needed, Bill-to and Ship-to contact information.